Specific capture and temperature-mediated release of cells in an aptamer-based microfluidic device

Cell isolation from mixed populations is a foundational process in cell biology and clinical testing. Traditional methods rely on physical traits like size and density, or on surface-bound ligands such as antibodies. These approaches often struggle with specificity and recovery efficiency. Recent advances in microfluidics have improved cell capture and purification using affinity-based methods. However, a key limitation remains: retrieving live cells from affinity surfaces without damaging them. This gap motivated the development of a new approach that enables both selective capture and controlled release. Prior research has shown that antibody-based systems can capture cells, but releasing them intact has been a challenge. No prior work had resolved how to reversibly disrupt these interactions while preserving cell viability. The need for a system that allows temperature-triggered release without harming cells remains unmet in the field.

The goal of this study was to develop a microfluidic device that enables both specific cell capture and controlled release. The researchers aimed to address the limitations of current affinity-based methods by designing a system that allows temperature-driven release of live cells. This approach would allow for cell isolation followed by downstream analysis without compromising cell viability. The study focused on using aptamers, which are known for their high specificity and binding affinity. The researchers also sought to integrate temperature control into the device to enable reversible cell release. By combining aptamer-based capture with microfluidic technology, the team aimed to improve efficiency and reduce costs in cell isolation. The study tested whether this system could be used repeatedly without degrading the functional surface. The ultimate purpose was to provide a practical tool for cell isolation and retrieval in both research and diagnostic settings.

The researchers designed a microfluidic device with a microchamber for cell capture. Surface-immobilized aptamers were used to selectively bind target cells. The device included integrated heaters and a temperature sensor to control the release process. The temperature was adjusted to disrupt the cell-aptamer interaction without damaging the cells. The device was tested using CCRF-CEM cells, a human T-cell leukemia line. Cell capture was evaluated using fluorescence imaging and flow cytometry. Viability of released cells was assessed using live/dead staining. The regenerability of the aptamer-functionalized surface was tested through multiple cycles of capture and release. The system's performance was compared to traditional antibody-based methods in terms of specificity and recovery rate. The device was optimized for minimal cell loss and maximum retrieval efficiency.

The device successfully captured CCRF-CEM cells using surface-immobilized aptamers. Temperature changes triggered the release of cells without affecting their viability. The released cells remained functional and could be collected for further analysis. The aptamer-functionalized surface was shown to be regenerable after multiple cycles. The system achieved a high capture efficiency and a recovery rate of over 85%. The temperature-mediated release process was repeatable and did not damage the device's functional surface. The results demonstrated that the device could be used for multiple rounds of cell capture and release. The system outperformed traditional antibody-based methods in terms of specificity and ease of cell retrieval.

The study demonstrated that a microfluidic device with surface-immobilized aptamers can achieve specific cell capture and temperature-mediated release. The device allows for non-destructive retrieval of live cells, which is a significant improvement over current methods. The temperature-controlled release mechanism was shown to be effective and repeatable. The aptamer-functionalized surface remained functional after multiple cycles of use. The system's performance with CCRF-CEM cells suggests it could be adapted for other cell types. The device offers a practical solution for cell isolation and retrieval in both research and clinical settings. The authors propose that this approach could be integrated into existing diagnostic workflows. The results suggest that the device could reduce costs and improve efficiency in cell isolation processes.